EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Omega Healthcare Investors's enterprise value is R$46,905 Mil.
Omega Healthcare Investors's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was R$6,539 Mil. Therefore, Omega Healthcare Investors's EV-to-EBITDA for today is 7.17.
The historical rank and industry rank for Omega Healthcare Investors's EV-to-EBITDA or its related term are showing as below:
BSP:O2HI34'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.3 Med: 15.83 Max: 31.8
Current: 15.27
During the past 13 years, the highest EV-to-EBITDA of Omega Healthcare Investors was 31.80. The lowest was 11.30. And the median was 15.83.
BSP:O2HI34's EV-to-EBITDA is ranked worse than 50.58% of 690
companies
in the REITs industry
Industry Median: 15.205
vs BSP:O2HI34: 15.27
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Omega Healthcare Investors's PE Ratio (TTM) for today is calculated as:
Omega Healthcare Investors's share price for today is R$77.02.
Omega Healthcare Investors's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$11.174.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:O2HI34 vs DOC, AHR, CTRE: EV-to-EBITDA Comparison
For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omega Healthcare Investors EV-to-EBITDA vs REITs Industry
For the REITs industry and Real Estate sector, Omega Healthcare Investors's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Omega Healthcare Investors's EV-to-EBITDA falls into.
Omega Healthcare Investors's current Enterprise Value is R$46,905 Mil.
Omega Healthcare Investors's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$6,539 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omega Healthcare Investors (BSP:O2HI34) has a EV-to-EBITDA of 7.17 as of Jun. 25, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Omega Healthcare Investors. This is 55% below median its historical median of 15.83. Over the past decade, Omega Healthcare Investors' EV-to-EBITDA has ranged from 11.30 to 31.80. According to the industry distribution chart, Omega Healthcare Investors ranks #349 out of 690 companies in the REITs industry, placing it in the top 50.6%.
Is Omega Healthcare Investors' EV-to-EBITDA too high?
Omega Healthcare Investors' current EV-to-EBITDA of 7.17 is 55% below median its 10-year median of 15.83. Over the past 10 years, this metric has ranged from a low of 11.30 to a high of 31.80. The REITs industry median EV-to-EBITDA is 15.21. Omega Healthcare Investors' value of 7.17 is 52.8% below this industry median. Based on the distribution chart, Omega Healthcare Investors ranks #349 out of 690 companies in the REITs industry, which is below the industry midpoint. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' EV-to-EBITDA compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #349 out of 690 companies for EV-to-EBITDA. This places Omega Healthcare Investors in the lower half of its industry. The industry median EV-to-EBITDA is 15.21. Omega Healthcare Investors' value of 7.17 is 52.8% below this benchmark. Historically, Omega Healthcare Investors' own EV-to-EBITDA has ranged from 11.30 to 31.80 over the past decade. While the company's 10-year median is 15.83 vs. the industry median of 15.21, Omega Healthcare Investors has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a REITs company?
The median EV-to-EBITDA among REITs companies is 15.21, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Healthcare Investors's current EV-to-EBITDA of 7.17 is 52.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Omega Healthcare Investors. For the REITs industry, the median EV-to-EBITDA is 15.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current EV-to-EBITDA is 7.17, which is 55% below median its own 10-year median of 15.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$60.64, compared to a current price of R$77.02 — trading 27% above its estimated fair value. The current EV-to-EBITDA is 7.17, which is 55% below median its 10-year median of 15.83 and 52.8% below the REITs industry median of 15.21. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current EV-to-EBITDA is 7.17 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?
Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued.
The current stock price of R$77.02 is trading 27% above its estimated GF Value™ of R$60.64.
GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.
Key valuation signals for BSP:O2HI34:
EV-to-EBITDA: 7.17 (55% below median its 10-year median of 15.83)
GF Value™: R$60.64 vs. price of R$77.02 (27% above fair value)
Industry Position: 52.8% below the REITs median (#349 of 690)
No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score
Get the complete analysis for BSP:O2HI34
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:O2HI34 has been successfully added to your 
